Top Institutional Investors

Invenomic Capital Management LP — 13F Holdings & Portfolio

CIK 1769456 · latest 13F-HR filed 2026-08-14

Backtest portfolio

Invenomic Capital Management LP manages $1.67B in 13F-reported U.S. long-equity assets across 116 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are GPN (3.82%), UHS (3.79%), WDAY (3.48%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 21 new positions and exited 54; 30 existing positions rose in reported value and 53 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$1.67B

Long-equity book

Holdings
116

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+21 / −54 / ↑30 / ↓53

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26
GPN3.8% · -4%UHS3.8% · +131%WDAY3.5% · -15%XRAY3.1% · +12%SPSC3.0% · +229%PVH2.6% · -25%BDX2.5% · newFIS2.5% · +3%CHTR2.4% · newEGO2.1% · -19%OMC2.1% · +7%LYFT2.1% · -20%BILL2.0% · -12%CLVT1.8% · +7%CRM1.8% · -14%INGM1.8% · -22%INTU1.7% · newVTRS1.6% · -46%CNMD1.6% · -10%OC1.5% · -9%FISV1.5% · -17%SON1.5% · -0%ABM1.4% · -5%NOMD1.4% · +7%ST1.3% · -50%MNDY1.3% · +45%INGR1.2% · -15%UPWK1.2% · +26%HURN1.2% · newDOLE1.2% · -19%PATH1.2% · +9%FIVN1.1% · -5%DLO1.1% · +446%PRGS1.0% · newLZ1.0% · -8%HAE1.0% · -68%ENOV1.0% · -14%TNC1.0% · -48%COUR0.9% · -21%PENN0.9% · -52%CMCSA0.9% · +620%ZBH0.9% · +5%GEN0.9% · +132%GEHC0.9% · newPRU0.9% · +13%KBR0.8% · newRYZ0.7% · -21%CHWY0.7% · newCXT0.7% · +58%MDT0.7% · newHUBS0.7% · +148%SSTK0.7% · -4%CAL0.7% · -18%IART0.6% · -43%HELE0.6% · -45%MKTX0.6% · newMTN0.6% · -32%FLGT0.6% · -18%MATV0.6% · -30%FLO0.6% · +11%

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 29.2%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 31, 2026.

Assets Under Management
$3.39B
Discretionary
$3.39B
Employees
17
Accounts
6
Address
211 CONGRESS ST
8TH FLOOR
BOSTON, MA 02110
Phone
(617) 729-2323
Website
Name Title / Status Ownership Type
DESCHAINE, BENJAMIN, ROBERT ControlPRESIDENT
since Jul 2019
Less than 5%Individual
Harris, Nicholas, Christopher Messina ControlCHIEF COMPLIANCE OFFICER
since Dec 2024
Less than 5%Individual
INVENOMIC GP LLC ControlGENERAL PARTNER
since Dec 2015
Less than 5%Domestic Entity
MOTAMED, ALI, NMN ControlMANAGING PARTNER
since Dec 2015
75% or moreIndividual
PLATYPUS PARTNERS, LLCLIMITED PARTNER
since Jul 2019
5–10%Domestic Entity
Grabe, Douglas, Scott Control
Indirect owner via PLATYPUS PARTNERS, LLC
MEMBER
since Jul 2015
25–50%Individual
Grabe, Laura, Suzanne Control
Indirect owner via PLATYPUS PARTNERS, LLC
MEMBER
since Jul 2015
25–50%Individual
MOTAMED, ALI, NMN Control
Indirect owner via INVENOMIC GP LLC
MANAGING MEMBER
since Dec 2015
75% or moreIndividual
Robinson, Caryn, Grabe Control
Indirect owner via PLATYPUS PARTNERS, LLC
MEMBER
since Jul 2015
25–50%Individual
Taffe, Lisa, Grabe Control
Indirect owner via PLATYPUS PARTNERS, LLC
MEMBER
since Jul 2015
25–50%Individual
Ownership & leadership changes · 6 filings with changes since Apr 13, 2017

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Dec 13, 2024 filing
  • AddedHarris, Nicholas, Christopher Messina · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
  • ChangedDESCHAINE, BENJAMIN, ROBERT · title PRESIDENT AND CHIEF COMPLIANCE OFFICER → PRESIDENT
Nov 4, 2021 filing
  • No longer listedBALTER CAPITAL MANAGEMENT LLC · LIMITED PARTNER · 5–10% · listed since Jul 2019
  • No longer listedBALTER, BRADLEY, ROSS · MANAGING MEMBER · 50–75% · indirect via BALTER CAPITAL MANAGEMENT LLC · control person · listed since Mar 2007
  • No longer listedWARNER, JAY, CLARK · MEMBER · 25–50% · indirect via BALTER CAPITAL MANAGEMENT LLC · control person · listed since Mar 2007
Oct 27, 2020 filing
  • No longer listedGompper, Rebecca, Elise · CHIEF COMPLIANCE OFFICER · Less than 5% · listed since Nov 2017
  • ChangedDESCHAINE, BENJAMIN, ROBERT · title PRESIDENT → PRESIDENT AND CHIEF COMPLIANCE OFFICER
Sep 10, 2019 filing
  • AddedDESCHAINE, BENJAMIN, ROBERT · PRESIDENT · Less than 5% · control person
  • AddedGrabe, Douglas, Scott · MEMBER · 25–50% · indirect via PLATYPUS PARTNERS, LLC · control person
  • AddedGrabe, Laura, Suzanne · MEMBER · 25–50% · indirect via PLATYPUS PARTNERS, LLC · control person
  • AddedPLATYPUS PARTNERS, LLC · LIMITED PARTNER · 5–10%
  • AddedRobinson, Caryn, Grabe · MEMBER · 25–50% · indirect via PLATYPUS PARTNERS, LLC · control person
  • AddedTaffe, Lisa, Grabe · MEMBER · 25–50% · indirect via PLATYPUS PARTNERS, LLC · control person
  • AddedWARNER, JAY, CLARK · MEMBER · 25–50% · indirect via BALTER CAPITAL MANAGEMENT LLC · control person
  • ChangedBALTER CAPITAL MANAGEMENT LLC · title EQUITY INTEREST → LIMITED PARTNER; ownership Less than 5% → 5–10%; no longer a control person
Mar 29, 2018 filing
  • AddedBALTER CAPITAL MANAGEMENT LLC · EQUITY INTEREST · Less than 5% · control person
  • AddedBALTER, BRADLEY, ROSS · MANAGING MEMBER · 50–75% · indirect via BALTER CAPITAL MANAGEMENT LLC · control person
Dec 8, 2017 filing
  • No longer listedFRICANO, JAMES, A. · CCO · Less than 5% · listed since Feb 2017
  • AddedGompper, Rebecca, Elise · CHIEF COMPLIANCE OFFICER · Less than 5%
Apr 13, 2017 filing (earliest on record)
  • ListedFRICANO, JAMES, A. · CCO · Less than 5%
  • ListedINVENOMIC GP LLC · GENERAL PARTNER · Less than 5% · control person
  • ListedMOTAMED, ALI, NMN · MANAGING PARTNER · 75% or more · control person
  • ListedMOTAMED, ALI, NMN · MANAGING MEMBER · 75% or more · indirect via INVENOMIC GP LLC · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Invenomic Capital Management LP Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 GLOBAL PMTS INC GPN 37940X102 $64.0M 3.82% 881,579 SH
2 UNIVERSAL HLTH SVCS INC UHS 913903100 $63.5M 3.79% 427,264 SH
3 WORKDAY INC WDAY 98138H101 $58.3M 3.48% 476,106 SH
4 DENTSPLY SIRONA INC XRAY 24906P109 $52.1M 3.11% 4,909,808 SH
5 SPS COMM INC SPSC 78463M107 $49.7M 2.97% 869,410 SH
6 PVH CORPORATION PVH 693656100 $42.7M 2.55% 575,346 SH
7 BECTON DICKINSON & CO BDX 075887109 $41.3M 2.47% 273,182 SH
8 FIDELITY NATL INFORMATION SV FIS 31620M106 $41.2M 2.46% 1,060,601 SH
9 CHARTER COMMUNICATIONS INC CHTR 16119P108 $40.2M 2.40% 282,416 SH
10 ELDORADO GOLD CORP NEW EGO 284902509 $36.0M 2.15% 1,157,819 SH
11 OMNICOM GROUP INC OMC 681919106 $34.9M 2.08% 479,221 SH
12 LYFT INC LYFT 55087P104 $34.3M 2.05% 2,350,081 SH
13 BILL HOLDINGS INC BILL 090043100 $32.9M 1.96% 908,775 SH
14 CLARIVATE PLC CLVT G21810109 $30.8M 1.84% 14,261,471 SH
15 SALESFORCE INC CRM 79466L302 $30.3M 1.81% 193,300 SH
16 INGRAM MICRO HLDG CORP INGM 457152106 $29.6M 1.77% 1,077,596 SH
17 INTUIT INTU 461202103 $27.8M 1.66% 106,609 SH
18 VIATRIS INC VTRS 92556V106 $27.6M 1.65% 1,738,790 SH
19 CONMED CORP CNMD 207410101 $27.6M 1.65% 842,162 SH
20 OWENS CORNING NEW OC 690742101 $25.5M 1.53% 160,637 SH
21 FISERV INC FISV 337738108 $25.5M 1.52% 520,236 SH
22 SONOCO PRODS CO SON 835495102 $24.7M 1.47% 438,219 SH
23 ABM INDS INC ABM 000957100 $23.5M 1.41% 532,082 SH
24 NOMAD FOODS LTD NOMD G6564A105 $22.9M 1.37% 2,092,084 SH
25 SENSATA TECHNOLOGIES HLDG PL ST G8060N102 $22.4M 1.34% 470,222 SH
26 MONDAY COM LTD MNDY M7S64H106 $21.0M 1.26% 290,707 SH
27 INGREDION INC INGR 457187102 $20.9M 1.25% 220,493 SH
28 UPWORK INC UPWK 91688F104 $20.1M 1.20% 2,406,922 SH
29 HURON CONSULTING GROUP INC HURN 447462102 $19.8M 1.19% 220,073 SH
30 DOLE PLC DOLE G27907107 $19.6M 1.17% 1,430,966 SH
31 UIPATH INC PATH 90364P105 $19.4M 1.16% 1,787,590 SH
32 FIVE9 INC FIVN 338307101 $19.0M 1.14% 892,658 SH
33 DLOCAL LTD DLO G29018101 $18.1M 1.08% 1,395,170 SH
34 PROGRESS SOFTWARE CORP PRGS 743312100 $17.2M 1.03% 511,240 SH
35 LEGALZOOM COM INC LZ 52466B103 $16.4M 0.98% 2,676,821 SH
36 HAEMONETICS CORP MASS HAE 405024100 $16.2M 0.97% 216,217 SH
37 ENOVIS CORPORATION ENOV 194014502 $16.0M 0.95% 772,034 SH
38 TENNANT CO TNC 880345103 $16.0M 0.95% 182,387 SH
39 COURSERA INC COUR 22266M104 $15.8M 0.94% 2,798,362 SH
40 PENN ENTERTAINMENT INC PENN 707569109 $15.8M 0.94% 738,495 SH
41 COMCAST CORP NEW CMCSA 20030N101 $15.5M 0.92% 629,808 SH
42 ZIMMER BIOMET HOLDINGS INC ZBH 98956P102 $15.4M 0.92% 178,691 SH
43 GEN DIGITAL INC GEN 668771108 $15.2M 0.91% 610,309 SH
44 GE HEALTHCARE TECHNOLOGIES I GEHC 36266G107 $14.9M 0.89% 233,035 SH
45 PRUDENTIAL FINL INC PRU 744320102 $14.6M 0.87% 135,381 SH
46 KBR INC KBR 48242W106 $12.8M 0.76% 369,476 SH
47 RYERSON HLDG CORP RYZ 783754104 $12.5M 0.75% 508,048 SH
48 CHEWY INC CHWY 16679L109 $12.1M 0.72% 613,972 SH
49 CRANE NXT CO CXT 224441105 $12.0M 0.71% 233,914 SH
50 MEDTRONIC PLC MDT G5960L103 $11.9M 0.71% 152,330 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $1.67B 116 0001214659-26-010369
2026-03-31 2026-05-15 $2.18B 150 0001214659-26-006456
2025-12-31 2026-02-17 $2.15B 147 0001214659-26-001967
2025-09-30 2025-11-14 $2.07B 143 0001214659-25-016624
Filer Information
Address
211 CONGRESS STREET
8TH FLOOR
BOSTON, MA 02110
Phone
(617) 912-4972
Filing Manager
Invenomic Capital Management LP
BOSTON, MA
Signatory
Nicholas Harris
Chief Compliance Officer